Firm Overview

Since 2003, the Essex Partners (“EP”) principals have provided operational and financial support to lower middle market companies across a broad range of industries. EP was formed to invest in companies with defensible market positions, significant growth opportunities and sustainable competitive advantages.

Transaction Types

  • Control Buyouts

  • Management Buyouts

  • Growth Equity

  • Generational Transitions of Family Owned Businesses

Industry Focus

  • Healthcare

  • Business Services

  • Distribution

  • Retail / Franchise Related

  • Manufacturing


Essex Partners Completes Acquisition of ScarMD and Hematix for Platform Company SkinGenuity

Essex Partners, LLC, an independent sponsor and affiliate of Essex Capital Group, Inc., announced that it recently closed an add-on acquisition of a skincare product line that includes established, best-in-class scar (ScarMD) and bruise (Hematix) treatments. The acquisition will further diversify the product offering for Essex’s existing platform company, SkinGenuity, LLC.


Investment Criteria


Revenues of $5 -$50 million; EBITDA of $2 million+

Investment Structures

Equity and mezzanine debt

Investment Amounts

$2 -$20 million with capacity to finance larger investments


Control or minority positions

Investment Horizons

Long Term (no limitations)

Board Representation

Active Board Seat


United States